Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026; Type A meeting with FDA expected to occur within 30 daysOn track to submit regulatory applications for ...
Demonstrates 99.9% two-qubit gate fidelity at 28 nanosecond gate speed on prototype platformBERKELEY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results